Vagos en es it fr

Vagos Brand names, Vagos Analogs

Vagos Brand Names Mixture

  • No information avaliable

Vagos Chemical_Formula


Vagos RX_link

Vagos fda sheet

Vagos FDA

Vagos msds (material safety sheet)

Vagos MSDS

Vagos Synthesis Reference

H. Yasufumi et al.; U.S. Pat. 4,283,408 (1981)

Vagos Molecular Weight

337.449 g/mol

Vagos Melting Point

163-164 oC

Vagos H2O Solubility

1.1 mg/mL

Vagos State


Vagos LogP


Vagos Dosage Forms

Oral tablets; Rapid disintergrating tablets; Suspension; Injectable solution

Vagos Indication

For the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).

Vagos Pharmacology

Famotidine, a competitive histamine H2-receptor antagonist, is used to treat gastrointestinal disorders such as gastric or duodenal ulcer, gastroesophageal reflux disease, and pathological hypersecretory conditions. Famotidine inhibits many of the isoenzymes of the hepatic CYP450 enzyme system. Other actions of Famotidine include an increase in gastric bacterial flora such as nitrate-reducing organisms.

Vagos Absorption

The bioavailability of oral doses is 40-45%.

Vagos side effects and Toxicity

Intravenous, mouse: LD50 = 244.4mg/kg; Oral, mouse: LD50 = 4686 mg/kg. Symptoms of overdose include emesis, restlessness, pallor of mucous membranes or redness of mouth and ears, hypotension, tachycardia and collapse.

Vagos Patient Information

Famotidine is used to treat stomach and duodenal (upper small intestine) ulcers;
hypersecretory (increased acid secretion) conditions; heartburn and gastroesophageal
reflux disease (stomach contents bubbling into the esophagus causing pain). Notify your
physician if you are pregnant or nursing. Famotidine may be taken with or without food.
Shake the oral suspension vigorously for 5-10 seconds before taking. Unused oral
suspension should be discarded after 30 days. Notify your physician if you develop black,
tarry stools or coffee-ground vomit.

Vagos Organisms Affected

Humans and other mammals